Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)

Sangamo Therapeutics (SGMO) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น2.66 Billion

According to Sangamo Therapeutics 's latest financial reports the company has โ‚น2.66 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Sangamo Therapeutics - Cash on Hand chart (from 2000 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น3.59 B-46.67%
2023-12-31โ‚น6.74 B-70.65%
2022-12-31โ‚น22.97 B-18.03%
2021-12-31โ‚น28.02 B-40.25%
2020-12-31โ‚น46.90 B81.48%
2019-12-31โ‚น25.84 B-7.61%
2018-12-31โ‚น27.97 B80.09%
2017-12-31โ‚น15.53 B60.39%
2016-12-31โ‚น9.68 B-30.26%
2015-12-31โ‚น13.88 B22.45%
2014-12-31โ‚น11.34 B97.81%
2013-12-31โ‚น5.73 B64.8%
2012-12-31โ‚น3.47 B-21.82%
2011-12-31โ‚น4.45 B64.75%
2010-12-31โ‚น2.70 B-31.46%
2009-12-31โ‚น3.94 B26.48%
2008-12-31โ‚น3.11 B-2.08%
2007-12-31โ‚น3.18 B33.26%
2006-12-31โ‚น2.38 B13.02%
2005-12-31โ‚น2.11 B46.69%
2004-12-31โ‚น1.44 B-27.86%
2003-12-31โ‚น1.99 B-20.15%
2002-12-31โ‚น2.50 B-15.87%
2001-12-31โ‚น2.97 B0.27%
2000-12-31โ‚น2.96 B797.15%
1999-12-31โ‚น0.33 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Gilead Sciences
GILD
โ‚น660.20 B 24,714.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น244.77 B 9,099.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น848.50 B 31,791.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น355.78 B 13,272.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น414.05 B 15,462.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น1.667 T 62,575.58%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น132.76 B 4,890.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.636 T 61,400.54%๐Ÿ‡บ๐Ÿ‡ธ USA